Avita Medical Ltd. Company Profile
Avita Medical (www.avitamedical.com) develops and distributes regenerative and tissue-engineered products for the treatment of a broad range of wounds, scars and skin defects. The companyâs lead product, ReCell® Spray-On Skin®, is used in a wide variety of burns, plastic, reconstructive and cosmetic procedures. ReCell is patented, CE-marked for Europe, TGA-registered in Australia, and SFDA-cleared in China. ReCell is not available for sale in the United States; in the U.S. ReCell is an investigational device limited to investigational use.
News Articles
Australia’s Avita Raises Cash For Phase III ReCell Trials For Skin Culture Technology
Australia’s Avita Medical received funding from private investors and the U.S. military for a skin culture technology treatment aimed at treating wounds and burns as well as sores developed by bed-r...
Avita Health Leverages QuadraMed EHR to Establish Meaningful Use Attestation
QuadraMed® Corp. recently announced in a press release that Avita Health System has established QuadraMed's electronic health record (EHR) as a critical component of its Stage 1 Meaningful Use at...
Avita Medical Ltd. CEO William Dolphin, Ph.D. Interviewed by Stock News Now
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwire) -- 02/14/13 -- William Dolphin, Ph.D., the CEO of regenerative medicine company Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), was intervi...
Avita Medical Announces Manufacturing Advances
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwire) -- 08/27/12 -- Avita Medical Ltd. (ASX: AVH), (PINKSHEETS: AVMXF), (OTCQX: AVMXY), the regenerative medicine company, announced a brief su...
Avita Medical to Present at SoCalBio Investor Conference & Exhibition
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwire) -- 11/05/12 -- Regenerative medicine company Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY) today announced that it will be presenting at th...
A$10 Million Capital Raising Oversubscribed
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwire) -- 10/22/12 -- Regenerative medicine company Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY) today announced that following strong support...
Avita Medical Completes ISO Quality Audit, CE Mark Recertification
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwire) -- 02/13/13 -- Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY) Regenerative medicine company Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY) to...
Avita Medical Announces Free Issuance Period for Conversion of AVMXF Shares to AVMXY ADRs
Avita Medical Ltd. (ASX: AVH) (OTC: AVMXF) (OTCQX:AVMXY), the regenerative medicine company, today ann
Drugs and Medications
Avita(tretinoin cream)cream, 0.025% [MYLAN BERTEK PHARMACEUTICALS INC.]
AVITA(tretinoin cream)CREAM, 0.025%
PubMed Articles
None
Clinical Trials
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
PCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause mortality or non...
Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion?
The purpose of this study is to evaluate if BhCG testing to determine the completion of medical abortion simplifies the medical abortion protocol. Investigators hypothesize that women rand...
The Impact of Internationalize Medical Services to localPeople Seeking Medical Care
Recently The Department of Health of Taiwan has launched the "Internationalize Medical Services Flagship Program", expecting to promote Taiwan's high-quality of medical services to the int...
Development and Evaluation of a Medical Intervention for Early Childhood Caries
This study aimed to evaluate the effect of three forms of continuing medical education (CME) on provision of preventive dental services to Medicaid-enrolled children by medical personnel i...
Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator
This study assesses the effectiveness of intrauterine fibroid and polyp removal using the Interlace Medical 1st generation hysteroscopic morcellator device based on a retrospective review...
Companies
Avita Medical (www.avitamedical.com) develops and distributes regenerative and tissue-engineered products for the treatment of a broad range of wounds, scars and skin defects. The...
The Medical Affairs Company LLC
The Medical Affairs Company LLC is a full service Contract Medical Organization that provides pharmaceutical, biotechnology, and medical device industry clients a wide array of outsourcing capabil...
Headquartered in Amsterdam, Netherlands, Medical Brands provides consumers with solutions in the OTC to everyday medical problems. Medical Brands develops patents, registers and p...
MedBio Publications provides 5 key services: medical writing, medical editing, medical translation, medical illustration, and medical publishing. Our clients are primarily national and international m...
More Information about "Avita Medical Ltd." on BioPortfolio
We have published hundreds of Avita Medical Ltd. news stories on BioPortfolio along with dozens of Avita Medical Ltd. Clinical Trials and PubMed Articles about Avita Medical Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avita Medical Ltd. Companies in our database. You can also find out about relevant Avita Medical Ltd. Drugs and Medications on this site too.
